ライフサイエンスコーパス: citral

1 x10(5) for linalool and 39 and 1.0x10(8) for citral.

2 ll as carvacrol, thymol, trans-2-hexenal and citral.

3 xtent of solubilisation and stabilisation of citral.

4 h of the otherwise noncompetitive antagonist citral.

5 less sensitive to octanal and not blocked by citral.

6 makes other monoterpenes but not geraniol or citral.

7 -buthionine sulfoxamine increases potency of citral.

8 f p53, ER stress-dependent mode of action of citral.

9 ts of GEO were alpha-zingiberene (23.9%) and citral (21.7%).

10 Low concentrations of citral (3,7-dimethyl-2,6-octadienal), an inhibitor of re

11 substrates such as Fmoc-protected alaninal, citral, 5-cholesten-3-one, uridine 5'-aldehyde, 3'-ketou

12 riefly in mouse embryos at midgestation with citral (a general alcohol dehydrogenase antagonist that

13 basilicum) cv Sweet Dani consists mostly of citral (a mixture of geranial and neral), with lower lev

14 We also examined the effect on P450 of citral, a terpenoid alpha, beta-unsaturated aldehyde and

15 ar chaperone 4-phenylbutyric acid attenuates citral activity in SKOV-3 but not in ECC-1 and OVCAR-3 c

16 The excitation evoked by citral after blocking PI3K, could be suppressed by the a

17 re efficient in solubilising and stabilising citral against an acidic environment.

18 thiohemiacetal reaction intermediate, makes citral an excellent inhibitor whose selectivity is enhan

19 ot inhibited, either in vitro or in vivo, by citral, an inhibitor of retinal oxidase.

20 Citral and acyclic isoprenoids also act as inhibitors of

21 ding affinity between CjapOBP1, CjapOBP2 and citral and coniferyl aldehyde, respectively.

22 ment with retinoic acid synthase inhibitors, citral and diethylaminobenzaldehyde (DEAB), during neuru

23 ggest that kafirin-based films incorporating citral and quercetin have potential as bioactive packagi

24 Furthermore, incorporation of citral and quercetin significantly lowered the oxygen pe

25 ns its fast recovery following inhibition by citral and suggests that E1 may be the enzyme involved i

26 films incorporating the plant essential oil citral and the polyphenol quercetin.

27 weet Dani, whose glands contain geraniol and citral, and not in glands or leaves of another basil var

28 Limonene, linalool and citral are common non-phenolic terpenoid components of e

29 RalDH(II) does not recognize citral, benzaldehyde, acetaldehyde, and propanal efficie

30 The addition of quercetin and citral both imparted a yellowish colour to the films.

31 -furanyl)-9H-purin-6-amine], indicating that citral could also activate ACIII, presumably through the

32 monocytogenes, however, films incorporating citral exhibited the highest antimicrobial activity agai

33 The percentage composition of citral for leaves and flowers was 64.5% and 58% for the

34 surfactant systems, suggesting protection of citral from an acidic environment once it is incorporate

35 higher amounts of 2-isobutylthiazole, alpha-citral, hexanal, 3-hexen-1-ol, and 6-methyl-5-hepten-2-o

36 The rate of chemical degradation of citral in acidic aqueous solutions was found to be highe

37 This study indicates that citral in PEG-b-PCL nanoparticle formulation should be c

38 our transmission of the films decreased with citral incorporation but the water vapour permeability w

39 Citral increases intracellular oxygen radicals and this

40 In p53-expressing cells, citral increases phosphorylation of serine-15 of p53.

41 CAR-3 but not in p53-deficient SKOV-3 cells, citral induces G1/S cell cycle arrest and apoptosis as d

42 In SKOV-3 cells, citral induces the ER stress markers CHOP, GADD45, EDEM,

43 Here, we show that citral inhibits proliferation of multiple human cancer c

44 Citral is a 1 : 2 mixture of isomers: cis isomer neral a

45 Citral is a flavour component widely used in food and co

46 Evidence was obtained that citral is an effective mechanism-based inactivator of is

47 Thus, citral is an inhibitor and also a substrate.

48 Thus, citral is not suitable for use in attempts to distinguis

49 he response of native rat ORNs to octanol by citral is PI3K dependent; blocking PI3K activity with th

50 Citral, linalool and estragole were the major constituen

51 bition of p53 by pifithrin-alpha, attenuates citral-mediated apoptosis.

52 s that E1 may be the enzyme involved in vivo citral metabolism.

53 tioxidant behavior of limonene, linalool and citral occurs by co-oxidation with the substrate, due to

54 pour permeability was not affected by either citral or quercetin incorporation.

55 low concentrations of octanal and blocked by citral, other receptors were less sensitive to octanal a

56 wever, when trained to recognize mixtures of citral (partial 17 agonist, inhibitor) and octanal, rats

57 of endogenous retinoic acid was inhibited by citral prior to the initial stage of rod differentiation

58 the M05/6-311+g(2df,2p) level indicate that citral reacts selectively at the aldehyde C-H having act

59 xy-3-oxo-3H-xanthen-9-yl)-(9CI)]) suppressed citral's inhibition of the response to octanol, indicati

60 Citral, the major contributor to the lemony flavour, was

61 imonene, gamma-terpinene, p-cymene and alpha-citral) to the fruit volatiles and enhanced the fermenta

62 cysteine decreases phosphorylation of p53 in citral-treated ECC-1 and OVCAR-3.

63 Citral was found to be the major component, the base ext

64 l, indicating that the activation of PI3K by citral was G-protein dependent, consistent with the idea

65 eased and elongation at break increased when citral was incorporated, whereas addition of quercetin d

66 Km values for citral were 4 microM for E1, 1 microM for E2 and 0.1 mic

67 The monoterpenoid, citral, when delivered through PEG-b-PCL nanoparticles i

68 The Vmax for citral with the E1 isozyme was higher than those of the